BRIEF published on 06/10/2025 at 10:11, 1 year ago Edison Releases Report on BB Biotech Amidst Sector Challenges Investment Strategies Market Volatility Biotech Sector BB Biotech Long-term Outlook
PRESS RELEASE published on 06/10/2025 at 10:06, 1 year ago Edison issues report on BB Biotech (BION) Edison issues report on BB Biotech (BION) covering the recent challenges and opportunities in the biotech sector, including market volatility and long-term outlook Edison Market Volatility Biotech Sector BB Biotech Long-term Outlook
BRIEF published on 04/25/2025 at 07:05, 1 year 2 months ago BB Biotech AG annonce une perte nette de 241 millions de francs suisses au premier trimestre 2025 Perte Nette Portefeuille D'investissement Développement De Médicaments BB Biotech Rapport Intermédiaire
BRIEF published on 04/25/2025 at 07:05, 1 year 2 months ago BB Biotech AG Reports CHF 241 Million Net Loss for Q1 2025 Drug Development Net Loss Investment Portfolio Interim Report BB Biotech
BRIEF published on 04/25/2025 at 07:05, 1 year 2 months ago BB Biotech Q1 2025: Portfolio Adjustments Amid Volatile Market Market Volatility Investment Portfolio Biotech Sector BB Biotech FDA Approvals
BRIEF published on 04/25/2025 at 07:05, 1 year 2 months ago BB Biotech T1 2025 : ajustements de portefeuille dans un contexte de marché volatil Volatilité Du Marché Portefeuille D'investissement BB Biotech Secteur Biotechnologique Approbations De La FDA
PRESS RELEASE published on 04/25/2025 at 07:00, 1 year 2 months ago EQS-Adhoc: BB Biotech AG publishes its interim report BB Biotech AG publishes its interim report covering the first three months of 2025 revealing a net loss of CHF 241 mn. More information at report.bbbiotech.ch/Q125 Financial Results Investment Company BB Biotech AG Interim Report Business Activities
PRESS RELEASE published on 04/25/2025 at 07:00, 1 year 2 months ago BB Biotech Q1 2025: Sharpened portfolio focus amid continued market volatility BB Biotech AG reports net loss in Q1 2025 due to market volatility. Portfolio focus on innovative biotech companies above USD 1 bn. Details on exits and regulatory milestones Market Volatility BB Biotech AG Biotech Companies Q1 2025 Portfolio Focus
BRIEF published on 03/19/2025 at 17:50, 1 year 3 months ago BB Biotech AG Shareholders Approve Dividend and Re-Elect Board Investment Strategy Dividend Board Re-election BB Biotech AGM 2025
BRIEF published on 03/19/2025 at 17:50, 1 year 3 months ago Les actionnaires de BB Biotech AG approuvent le dividende et réélisent le conseil d'administration Dividende Stratégie D'investissement Réélection Du Conseil D'administration BB Biotech Assemblée Générale Annuelle 2025
Published on 06/27/2026 at 01:40, 11 hours 1 minute ago Polaris Renewable Energy Announces Results of Director Elections at Annual and Special Meeting
Published on 06/27/2026 at 00:00, 12 hours 41 minutes ago Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
Published on 06/26/2026 at 23:00, 13 hours 41 minutes ago Canadian North Resources Inc. Announces Results of 2026 Annual General and Special Shareholders Meeting
Published on 06/26/2026 at 22:50, 13 hours 51 minutes ago Banyan Gold Files Technical Report for AurMac Project, Yukon, Canada
Published on 06/26/2026 at 22:15, 14 hours 26 minutes ago Revive Therapeutics Announces Proposed Private Placement
Published on 06/27/2026 at 00:05, 12 hours 36 minutes ago EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss
Published on 06/27/2026 at 00:04, 12 hours 37 minutes ago Persistent and Nagarro sign Business Combination Agreement to form the Persistent - Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 13 hours 5 minutes ago Persistent and Nagarro sign Business Combination Agreement to form the Persistent – Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 13 hours 5 minutes ago EQS-Adhoc: Nagarro SE: Nagarro signs business combination agreement with Persistent Systems and supports voluntary public takeover offer to all shareholders at EUR 81 per share
Published on 06/26/2026 at 23:27, 13 hours 14 minutes ago EQS-WpÜG: Takeover Offer / Target company: Nagarro SE; Bidder: Galaxy Germany Holding SE
Published on 06/26/2026 at 17:45, 18 hours 56 minutes ago Descriptif du programme de rachat d'actions
